PROCTER & GAMBLE HEALTH | TTK HEALTHCARE | PROCTER & GAMBLE HEALTH/ TTK HEALTHCARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.4 | 33.1 | 103.9% | View Chart |
P/BV | x | 10.5 | 2.3 | 465.0% | View Chart |
Dividend Yield | % | 2.0 | 0.7 | 307.9% |
PROCTER & GAMBLE HEALTH TTK HEALTHCARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
TTK HEALTHCARE Mar-23 |
PROCTER & GAMBLE HEALTH/ TTK HEALTHCARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,106 | 485.2% | |
Low | Rs | 3,883 | 668 | 581.7% | |
Sales per share (Unadj.) | Rs | 740.7 | 513.2 | 144.3% | |
Earnings per share (Unadj.) | Rs | 138.2 | 31.6 | 437.3% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 40.7 | 381.5% | |
Dividends per share (Unadj.) | Rs | 95.00 | 10.00 | 950.0% | |
Avg Dividend yield | % | 2.1 | 1.1 | 182.2% | |
Book value per share (Unadj.) | Rs | 447.6 | 674.7 | 66.3% | |
Shares outstanding (eoy) | m | 16.60 | 14.13 | 117.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.7 | 361.3% | |
Avg P/E ratio | x | 33.5 | 28.0 | 119.3% | |
P/CF ratio (eoy) | x | 29.8 | 21.8 | 136.7% | |
Price / Book Value ratio | x | 10.3 | 1.3 | 786.1% | |
Dividend payout | % | 68.7 | 31.6 | 217.2% | |
Avg Mkt Cap | Rs m | 76,761 | 12,529 | 612.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 1,234 | 167.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 7,251 | 169.6% | |
Other income | Rs m | 184 | 483 | 38.0% | |
Total revenues | Rs m | 12,480 | 7,734 | 161.4% | |
Gross profit | Rs m | 3,247 | 313 | 1,035.7% | |
Depreciation | Rs m | 281 | 128 | 219.4% | |
Interest | Rs m | 8 | 52 | 14.7% | |
Profit before tax | Rs m | 3,142 | 616 | 509.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 170 | 499.4% | |
Profit after tax | Rs m | 2,295 | 447 | 513.7% | |
Gross profit margin | % | 26.4 | 4.3 | 610.7% | |
Effective tax rate | % | 27.0 | 27.5 | 98.0% | |
Net profit margin | % | 18.7 | 6.2 | 302.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 10,664 | 109.8% | |
Current liabilities | Rs m | 6,791 | 2,108 | 322.2% | |
Net working cap to sales | % | 40.0 | 118.0 | 33.9% | |
Current ratio | x | 1.7 | 5.1 | 34.1% | |
Inventory Days | Days | 263 | 13 | 2,057.6% | |
Debtors Days | Days | 343 | 464 | 74.1% | |
Net fixed assets | Rs m | 10,617 | 994 | 1,068.6% | |
Share capital | Rs m | 166 | 141 | 117.5% | |
"Free" reserves | Rs m | 7,265 | 9,393 | 77.3% | |
Net worth | Rs m | 7,431 | 9,534 | 77.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 11,658 | 191.5% | |
Interest coverage | x | 409.1 | 12.8 | 3,204.5% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.6 | 88.5% | |
Return on assets | % | 10.3 | 4.3 | 240.8% | |
Return on equity | % | 30.9 | 4.7 | 659.1% | |
Return on capital | % | 42.4 | 7.0 | 604.3% | |
Exports to sales | % | 0 | 9.1 | 0.0% | |
Imports to sales | % | 13.1 | 1.4 | 926.5% | |
Exports (fob) | Rs m | NA | 657 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 102 | 1,571.1% | |
Fx inflow | Rs m | 1,465 | 657 | 223.0% | |
Fx outflow | Rs m | 1,605 | 163 | 986.4% | |
Net fx | Rs m | -140 | 494 | -28.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -261 | -905.0% | |
From Investments | Rs m | -215 | 330 | -65.2% | |
From Financial Activity | Rs m | -985 | -124 | 792.5% | |
Net Cashflow | Rs m | 1,160 | -55 | -2,092.9% |
Indian Promoters | % | 0.0 | 74.6 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 3.0 | 667.9% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 25.4 | 189.4% | |
Shareholders | 56,778 | 17,221 | 329.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | TTK HEALTHCARE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.14% | -0.38% | -0.44% |
1-Month | -3.36% | 3.32% | 2.15% |
1-Year | -0.17% | 16.40% | 49.82% |
3-Year CAGR | -9.52% | 44.87% | 14.21% |
5-Year CAGR | 4.46% | 17.45% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the TTK HEALTHCARE share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of TTK HEALTHCARE the stake stands at 74.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of TTK HEALTHCARE.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
TTK HEALTHCARE paid Rs 10.0, and its dividend payout ratio stood at 31.6%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of TTK HEALTHCARE.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.